Chronic Kidney Disease Clinical Trials in Montpellier
4 recruitingMontpellier, France
Showing 1–4 of 4 trials
Recruiting
Phase 3
A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body, and the Effects it Has on the Body When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker in Children With Chronic Kidney Disease and Proteinuria
Chronic Kidney DiseaseProteinuria
Bayer219 enrolled154 locationsNCT05196035
Recruiting
Not Applicable
Proteinuria in Renal Transplant Patients Treated with Dapagliflozin
Chronic Kidney Diseases
University Hospital, Montpellier70 enrolled1 locationNCT06165601
Recruiting
Not Applicable
Evaluation of Cardiovascular Risk Factors in Incident Dialysis Patients
Chronic Kidney Disease
University Hospital, Montpellier400 enrolled5 locationsNCT02813642
Recruiting
Not Applicable
New Biomarkers of Bone Mineral Metabolism as Cardiovascular Risk Factors in Chronic Kidney Disease Patients
Chronic Kidney Disease
University Hospital, Montpellier250 enrolled7 locationsNCT02808572